LYTIR

Company · SOPH

SOPHiA GENETICS SA

Nasdaq's symbol directory lists SOPH on Nasdaq as “SOPHiA GENETICS SA - Ordinary Shares”.

In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($278K); insiders sold on 69 occasions ($4.2M); 12 planned-sale notices; 1 filing by holders of 5% or more.

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $278K in total; Insider sales: $4.2M in total.Jun: Insider sales $922KJul: Insider sales $811KAug: Insider sales $1.2MSep: Insider sales $244KOct: Insider sales $796KNov: Insider purchases $278KNov: Insider sales $205KDecJanFebMarAprMayJunJulAugSepOctNov$278K$1.2M
Insider purchases above the line: $278KInsider sales below: $4.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Jurgi Camblong, Executive Chairman sold on 16 days all under a 10b5-1 plan latest Nov 10, 2026 sold $2.2M
  2. Xu Zhenyu, Chief Scientific Officer sold on 15 days all under a 10b5-1 plan latest Nov 13, 2026 sold $730K
  3. Menu Philippe, Chief Medical Officer sold on 11 days all under a 10b5-1 plan latest Nov 12, 2026 sold $402K
  4. Ross Muken, Chief Executive Officer sold on 4 days all under a 10b5-1 plan bought on 1 day latest Nov 6, 2026 sold $137K · bought $137K
  5. Verma Abhimanyu, Chief Technology Officer sold on 7 days all under a 10b5-1 plan latest Oct 5, 2026 sold $266K
  6. George Cardoza, Chief Financial Officer sold on 4 days all under a 10b5-1 plan bought on 1 day latest Nov 6, 2026 sold $32K · bought $141K
  7. HIBBS KATHY L sold on 3 days all under a 10b5-1 plan latest Nov 10, 2026 sold $154K
  8. Valente Manuela, Chief People Officer sold on 3 days all under a 10b5-1 plan latest Oct 5, 2026 sold $135K
  9. Van Well Daan, Chief Legal Officer sold on 4 days all under a 10b5-1 plan latest Nov 16, 2026 sold $117K
  10. Puylaert Kevin, Chief Sales Officer sold on 2 days latest Oct 5, 2026 sold $3K
Every trade (71)
  1. SELLVan Well Daan, Chief Legal Officer sold Nov 16, 2026 1,224 shares 10b5-1 plan (scheduled) filing $9K
  2. SELLXu Zhenyu, Chief Scientific Officer sold Nov 13, 2026 4,000 shares 10b5-1 plan (scheduled) filing $32K
  3. SELLMenu Philippe, Chief Medical Officer sold Nov 12, 2026 5,000 shares 10b5-1 plan (scheduled) filing $38K
  4. SELLJurgi Camblong, Executive Chairman sold Nov 10, 2026 8,500 shares 10b5-1 plan (scheduled) filing $66K
  5. SELLHIBBS KATHY L sold Nov 10, 2026 6,250 shares 10b5-1 plan (scheduled) filing $48K
  6. SELLVan Well Daan, Chief Legal Officer sold Nov 9, 2026 1,411 shares 10b5-1 plan (scheduled) filing $10K
  7. BUYGeorge Cardoza, Chief Financial Officer bought Nov 6, 2026 20,000 shares filing $141K
  8. BUYRoss Muken, Chief Executive Officer bought Nov 6, 2026 20,000 shares filing $137K
  9. SELLXu Zhenyu, Chief Scientific Officer sold Oct 13, 2026 4,000 shares 10b5-1 plan (scheduled) filing $29K
  10. SELLJurgi Camblong, Executive Chairman sold Oct 12, 2026 8,500 shares 10b5-1 plan (scheduled) filing $62K
  11. SELLMenu Philippe, Chief Medical Officer sold Oct 12, 2026 5,000 shares 10b5-1 plan (scheduled) filing $36K
  12. SELLJurgi Camblong, Executive Chairman sold Oct 5, 2026 40,172 shares 10b5-1 plan (scheduled) filing $327K
  13. SELLRoss Muken, Chief Executive Officer sold Oct 5, 2026 9,838 shares 10b5-1 plan (scheduled) filing $80K
  14. SELLMenu Philippe, Chief Medical Officer sold Oct 5, 2026 7,394 shares 10b5-1 plan (scheduled) filing $60K
  15. SELLXu Zhenyu, Chief Scientific Officer sold Oct 5, 2026 7,394 shares 10b5-1 plan (scheduled) filing $60K
  16. SELLVan Well Daan, Chief Legal Officer sold Oct 5, 2026 6,168 shares 10b5-1 plan (scheduled) filing $50K
  17. SELLVerma Abhimanyu, Chief Technology Officer sold Oct 5, 2026 5,284 shares 10b5-1 plan (scheduled) filing $43K
  18. SELLValente Manuela, Chief People Officer sold Oct 5, 2026 4,240 shares 10b5-1 plan (scheduled) filing $34K
  19. SELLGeorge Cardoza, Chief Financial Officer sold Oct 5, 2026 1,592 shares 10b5-1 plan (scheduled) filing $13K
  20. SELLPuylaert Kevin, Chief Sales Officer sold Oct 5, 2026 216 shares 2 legs combined filing $2K
  21. SELLGeorge Cardoza, Chief Financial Officer sold Sep 21, 2026 774 shares 10b5-1 plan (scheduled) filing $6K
  22. SELLRoss Muken, Chief Executive Officer sold Sep 21, 2026 422 shares 10b5-1 plan (scheduled) filing $4K
  23. SELLMenu Philippe, Chief Medical Officer sold Sep 14, 2026 5,000 shares 10b5-1 plan (scheduled) filing $39K
  24. SELLXu Zhenyu, Chief Scientific Officer sold Sep 14, 2026 4,000 shares 10b5-1 plan (scheduled) filing $32K
  25. SELLVan Well Daan, Chief Legal Officer sold Sep 11, 2026 6,168 shares 10b5-1 plan (scheduled) filing $47K
  26. SELLJurgi Camblong, Executive Chairman sold Sep 10, 2026 8,500 shares 10b5-1 plan (scheduled) filing $65K
  27. SELLHIBBS KATHY L sold Sep 8, 2026 6,250 shares 10b5-1 plan (scheduled) filing $51K
  28. SELLXu Zhenyu, Chief Scientific Officer sold Aug 27, 2026 10,000 shares 10b5-1 plan (scheduled) filing $89K
  29. SELLHIBBS KATHY L sold Aug 25, 2026 6,250 shares 10b5-1 plan (scheduled) filing $54K
  30. SELLMenu Philippe, Chief Medical Officer sold Aug 25, 2026 5,000 shares 10b5-1 plan (scheduled) filing $43K
  31. SELLVerma Abhimanyu, Chief Technology Officer sold Aug 24, 2026 5,000 shares 10b5-1 plan (scheduled) filing $44K
  32. SELLXu Zhenyu, Chief Scientific Officer sold Aug 21, 2026 5,408 shares 10b5-1 plan (scheduled) filing $45K
  33. SELLXu Zhenyu, Chief Scientific Officer sold Aug 20, 2026 4,592 shares 10b5-1 plan (scheduled) filing $39K
  34. SELLValente Manuela, Chief People Officer sold Aug 19, 2026 10,000 shares 10b5-1 plan (scheduled) filing $79K
  35. SELLXu Zhenyu, Chief Scientific Officer sold Aug 19, 2026 10,000 shares 10b5-1 plan (scheduled) filing $79K
  36. SELLVerma Abhimanyu, Chief Technology Officer sold Aug 19, 2026 5,000 shares 10b5-1 plan (scheduled) filing $41K
  37. SELLXu Zhenyu, Chief Scientific Officer sold Aug 13, 2026 4,000 shares 10b5-1 plan (scheduled) filing $30K
  38. SELLMenu Philippe, Chief Medical Officer sold Aug 12, 2026 5,000 shares 10b5-1 plan (scheduled) filing $38K
  39. SELLJurgi Camblong, Executive Chairman sold Aug 10, 2026 8,500 shares 10b5-1 plan (scheduled) filing $65K
  40. SELLJurgi Camblong, Executive Chairman sold Aug 7, 2026 20,000 shares 10b5-1 plan (scheduled) filing $145K
  41. SELLXu Zhenyu, Chief Scientific Officer sold Aug 7, 2026 17,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $124K
  42. SELLVerma Abhimanyu, Chief Technology Officer sold Aug 7, 2026 5,000 shares 10b5-1 plan (scheduled) filing $38K
  43. SELLXu Zhenyu, Chief Scientific Officer sold Aug 5, 2026 3,000 shares 10b5-1 plan (scheduled) filing $21K
  44. SELLJurgi Camblong, Executive Chairman sold Aug 4, 2026 20,000 shares 10b5-1 plan (scheduled) filing $138K
  45. SELLXu Zhenyu, Chief Scientific Officer sold Aug 4, 2026 10,000 shares 10b5-1 plan (scheduled) filing $69K
  46. SELLVerma Abhimanyu, Chief Technology Officer sold Aug 4, 2026 5,000 shares 10b5-1 plan (scheduled) filing $35K
  47. SELLMenu Philippe, Chief Medical Officer sold Jul 27, 2026 5,000 shares 10b5-1 plan (scheduled) filing $28K
  48. SELLJurgi Camblong, Executive Chairman sold Jul 21, 2026 20,000 shares 10b5-1 plan (scheduled) filing $133K
  49. SELLJurgi Camblong, Executive Chairman sold Jul 20, 2026 24,381 shares 2 legs combined 10b5-1 plan (scheduled) filing $153K
  50. SELLMenu Philippe, Chief Medical Officer sold Jul 13, 2026 5,000 shares 10b5-1 plan (scheduled) filing $29K
  51. SELLXu Zhenyu, Chief Scientific Officer sold Jul 13, 2026 4,000 shares 10b5-1 plan (scheduled) filing $23K
  52. SELLJurgi Camblong, Executive Chairman sold Jul 10, 2026 8,500 shares 10b5-1 plan (scheduled) filing $48K
  53. SELLJurgi Camblong, Executive Chairman sold Jul 7, 2026 17,685 shares 10b5-1 plan (scheduled) filing $93K
  54. SELLJurgi Camblong, Executive Chairman sold Jul 6, 2026 22,486 shares 10b5-1 plan (scheduled) filing $118K
  55. SELLRoss Muken, Chief Executive Officer sold Jul 6, 2026 9,838 shares 10b5-1 plan (scheduled) filing $51K
  56. SELLXu Zhenyu, Chief Scientific Officer sold Jul 6, 2026 7,393 shares 10b5-1 plan (scheduled) filing $38K
  57. SELLMenu Philippe, Chief Medical Officer sold Jul 6, 2026 7,393 shares 10b5-1 plan (scheduled) filing $38K
  58. SELLVerma Abhimanyu, Chief Technology Officer sold Jul 6, 2026 5,285 shares 10b5-1 plan (scheduled) filing $27K
  59. SELLValente Manuela, Chief People Officer sold Jul 6, 2026 4,241 shares 10b5-1 plan (scheduled) filing $21K
  60. SELLGeorge Cardoza, Chief Financial Officer sold Jul 6, 2026 1,592 shares 10b5-1 plan (scheduled) filing $8K

Showing the latest 60 of 71.

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. DAAN GUIDO MARIA VAN WELL filed Nov 16, 2026 Officer 1,224 shares planned sale date 11/16/2026 filing $10K
  2. DAAN GUIDO MARIA VAN WELL filed Nov 9, 2026 Officer 1,411 shares planned sale date 11/09/2026 filing $10K
  3. JURGI CAMBLONG filed Oct 5, 2026 Director 65,672 shares planned sale date 10/05/2026 filing $530K
  4. PHILIPPE MENU filed Oct 5, 2026 Officer 22,394 shares planned sale date 10/05/2026 filing $181K
  5. ZHENYU XU filed Oct 5, 2026 Officer 19,394 shares planned sale date 10/05/2026 filing $157K
  6. ROSS J MUKEN filed Oct 5, 2026 Director 9,838 shares planned sale date 10/05/2026 filing $79K
  7. DAAN GUIDO MARIA VAN WELL filed Oct 5, 2026 Officer 6,168 shares planned sale date 10/05/2026 filing $50K
  8. MANUELA VALENTE filed Oct 5, 2026 Officer 4,240 shares planned sale date 10/05/2026 filing $34K
  9. GEORGE CARDOZA filed Oct 5, 2026 Officer 1,592 shares planned sale date 10/05/2026 filing $13K
  10. GEORGE CARDOZA filed Sep 21, 2026 Officer 774 shares planned sale date 09/21/2026 filing $6K
  11. ROSS J MUKEN filed Sep 21, 2026 Director 422 shares planned sale date 09/21/2026 filing $3K
  12. DAAN GUIDO MARIA VAN WELL filed Sep 11, 2026 Officer 6,168 shares planned sale date 09/11/2026 filing $47K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Schindel Yair Chaim filed Nov 12, 2026 Schedule 13D/A may seek influence 5,318,023 shares filing 6.2%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.